I'm LongbridgeAI, I can summarize articles.ImmunityBio director Christobel Selecky sold 96,722 common shares worth approximately $870,677 between June 29-30, 2026, at roughly $9 per share. These sales followed the exercise of options for the same number of shares at $2.84-$2.99. Consequently, Selecky's direct holdings in ImmunityBio common stock have been reduced to zero.
- ImmunityBio director Christobel Selecky sold 96,722 shares on June 29-30, 2026 at about $9 per share. * The sales followed option exercises totaling 96,722 shares at $2.84-$2.99 per share. * Selecky’s direct common stock holdings fell to zero after the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001849739-26-000011), on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here